Medicare Enrolled
Dr. Meera Iyengar, MD
Medical Oncology · Clermont, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Iyengar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Iyengar? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Iyengar
Dr. Meera Iyengar is a medical oncology in Clermont, FL, with 17 years in practice. Based on federal Medicare data, Dr. Iyengar performed 170,600 Medicare services across 3,885 unique beneficiaries.
Between the years covered by Open Payments, Dr. Iyengar received a total of $7,437 from 62 pharmaceutical and/or device companies across 396 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Iyengar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice▲ Top 15% volume in FL$ $7,437 industry payments
Medicare Practice Summary
Medicare Utilization ↗170,600
Medicare services
Top 15% in FL for medical oncology
3,885
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~10,035 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 84,660 | $0 | $4 |
| Iron sucrose injection (Venofer) | 21,300 | $0 | $5 |
| Anti-nausea injection (aprepitant) | 16,900 | $1 | $5 |
| Filgrastim injection (Zarxio) for white blood cells | 12,240 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 12,180 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 7,151 | $6 | $23 |
| Complete blood count (CBC) with differential | 2,470 | $8 | $29 |
| Blood draw (venipuncture) | 2,442 | $8 | $9 |
| Dexamethasone injection (steroid) | 2,154 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,360 | $1 | $28 |
| Office visit, established patient (20-29 min) | 1,319 | $65 | $239 |
| Drug injection, under skin or into muscle | 1,200 | $10 | $69 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 562 | $1 | $6 |
| Injection of additional new drug or substance into vein | 535 | $12 | $61 |
| Office visit, established patient (30-39 min) | 483 | $96 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 480 | $0 | $9 |
| Administration of chemotherapy into vein, 1 hour or less | 338 | $97 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 318 | $22 | $84 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 308 | $47 | $189 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 210 | $54 | $206 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 175 | $15 | $56 |
| Injection, zoledronic acid, 1 mg | 172 | $6 | $69 |
| Administration of chemotherapy into vein, each additional hour | 156 | $22 | $79 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 152 | $3 | $11 |
| Injection of drug or substance into vein | 119 | $28 | $156 |
| Injection, diphenhydramine hcl, up to 50 mg | 109 | $1 | $3 |
| Prothrombin time test (blood clotting) | 98 | $4 | $15 |
| New patient office visit (45-59 min) | 84 | $117 | $453 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 79 | $15 | $56 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 78 | $134 | $562 |
| Automated urinalysis | 75 | $2 | $8 |
| Infusion, normal saline solution , 1000 cc | 75 | $2 | $7 |
| Infusion into a vein for hydration, each additional hour | 70 | $9 | $42 |
| Infusion into a vein for hydration, 31-60 minutes | 65 | $24 | $156 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 65 | $16 | $59 |
| Administration of additional new drug or substance into vein using push technique | 62 | $42 | $170 |
| Initial hospital admission, high complexity | 60 | $135 | $556 |
| Administration of additional new drug or substance into vein, 1 hour or less | 58 | $48 | $178 |
| Hospital follow-up visit, moderate complexity | 40 | $61 | $197 |
| Drawing of blood for a medical problem | 37 | $63 | $277 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 36 | $1 | $7 |
| Telephone medical discussion with physician, 5-10 minutes | 32 | $42 | $115 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 31 | $22 | $89 |
| New patient office visit, complex (60-74 min) | 28 | $146 | $585 |
| Office visit, established patient, complex (40-54 min) | 21 | $115 | $474 |
| Hospital follow-up visit, high complexity | 13 | $94 | $285 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
50.3% high complexity
45.3% medium
4.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,437
Total received (2018-2024)
Avg $1,062/year across 7 years
Top 49% in FL for medical oncology
62
Companies
396
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,334 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$103 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$954
2023$1,748
2022$1,079
2021$784
2020$353
2019$1,409
2018$1,110
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$850
Novartis Pharmaceuticals Corporation
$850
Genentech USA, Inc.
$511
Celgene Corporation
$443
E.R. Squibb & Sons, L.L.C.
$314
Amgen Inc.
$297
GlaxoSmithKline, LLC.
$288
EMD Serono, Inc.
$281
PFIZER INC.
$259
Pharmacyclics LLC, an AbbVie Company
$179
TerSera Therapeutics LLC
$174
BeiGene USA, Inc.
$171
Gilead Sciences, Inc.
$171
Merck Sharp & Dohme Corporation
$160
Seagen Inc.
$149
AstraZeneca Pharmaceuticals LP
$129
Pharmacyclics LLC, An AbbVie Company
$126
MACROGENICS, INC.
$125
Stemline Therapeutics Inc.
$119
GENZYME CORPORATION
$118
Merck Sharp & Dohme LLC
$106
TESARO, Inc.
$101
Rigel Pharmaceuticals, Inc.
$101
Janssen Pharmaceuticals, Inc
$93
SOBI, INC
$91
Astellas Pharma US Inc
$81
Karyopharm Therapeutics Inc.
$78
ABBVIE INC.
$77
Daiichi Sankyo Inc.
$76
Exelixis Inc.
$59
Incyte Corporation
$57
Boehringer Ingelheim Pharmaceuticals, Inc.
$56
Ipsen Biopharmaceuticals, Inc
$53
AMAG Pharmaceuticals, Inc.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$49
CSL Behring
$45
Taiho Oncology, Inc.
$41
JAZZ PHARMACEUTICALS INC.
$40
GE HealthCare
$37
Puma Biotechnology, Inc.
$31
Partner Therapeutics, Inc.
$31
Secura Bio, Inc.
$30
Novo Nordisk Inc
$29
Heron Therapeutics, Inc.
$28
MorphoSys, US Inc.
$23
Eisai Inc.
$21
Kite Pharma, Inc.
$21
Dendreon Pharmaceuticals LLC
$20
EUSA Pharma (US) LLC
$18
Lilly USA, LLC
$18
Agios Pharmaceuticals, Inc.
$18
Octapharma USA, Inc.
$18
R-Pharm US LLC
$17
PORTOLA PHARMACEUTICALS, INC.
$16
PUMA BIOTECHNOLOGY, INC.
$16
Myovant Sciences Inc.
$14
TAIHO ONCOLOGY, INC.
$14
Adaptive Biotechnologies Corporation
$13
Emmaus Medical, Inc.
$13
Dova Pharmaceuticals
$12
Aurobindo Pharma USA, Inc.
$12
Veracyte, Inc.
$1
Top 3 companies account for 29.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · ANDEXXA · Abraxane · Afstyla · Alecensa · Avastin · BLENREP · BOSULIF · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COPIKTRA · COSELA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ENHERTU · Endari · Enhertu · FERAHEME · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · Idhifa · Ixempra · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LEMTRADA · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · NUWIQ · Nerlynx · Neulasta · Novoeight · Nplate · OCREVUS · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · REBLOZYL · RYBREVANT · Revlimid · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · STELARA · SUSTOL · SUTENT · Sylvant · TAGRISSO · TASIGNA · TUKYSA · Tavalisse · Trodelvy · VENCLEXTA · VERZENIO · VONJO · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · XYNTHA · Xermelo · Xospata · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $4 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
22
Per 100K population
5.5
County median income
$69,956
Nearest hospital
ORLANDO HEALTH SOUTH LAKE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Iyengar is a mixed practice specialist, with above-average Medicare volume (top 15% in FL), and low-engagement industry engagement, with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Iyengar experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Iyengar performed 84,660 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Iyengar receive payments from pharmaceutical companies?
Yes. Dr. Iyengar received a total of $7,437 from 62 companies across 396 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Iyengar's costs compare to other medical oncologys in Clermont?
Dr. Iyengar's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Iyengar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Clermont
Browse medical oncologys in Clermont ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology